Indian Journal of Medical Biochemistry

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Related articles

VOLUME 25 , ISSUE 1 ( January-April, 2021 ) > List of Articles

REVIEW ARTICLE

Liver Function Tests: Biochemical Overview for Clinical Correlation

Joan B Kumar, BK Manjunatha Goud, Archana Kumar

Keywords : Biochemical parameters, Clinical biochemistry, Liver function test

Citation Information : Kumar JB, Goud BM, Kumar A. Liver Function Tests: Biochemical Overview for Clinical Correlation. Indian J Med Biochem 2021; 25 (1):31-37.

DOI: 10.5005/jp-journals-10054-0171

License: CC BY-NC 4.0

Published Online: 00-00-0000

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Aim and objective: To seamlessly integrate the biochemical knowledge and clinical application of liver function tests (LFTs) for easy reference. Background: The LFTs are one of the key investigations done during patient care. Several times during the patient workup, the complete panel of tests is done which is not necessary and adds extra financial burden on the patients. Medical students and young doctors should be aware of the clear indication of tests, to diagnose the condition and treat it accordingly. Healthcare professionals must use these test results in the proper perspective of patient history and physical examination to arrive at the correct diagnosis. Conclusion and clinical significance: This article highlights the main parameters tested in LFTs and their interpretation in a convenient and easily accessible format.

PDF Share
  1. Ozougwu JC, Eyo JE. Hepatoprotective effects of Allium cepa extracts on paracetamol-induced liver damage in rat. Afr J Biotechnol 2014;13(26):2679–2688. DOI: 10.5897/AJB2014.13815.
  2. Allen SE. The liver: anatomy, physiology, disease and treatment. USA: North Eastern University Press; 2002.
  3. Bloom W, Fawcett DW. Liver and gallbladder. In: A textbook of histology Bloom W, Fawcett DW, ed., Philadelphia: W. B. Saunders; 1975. pp. 688–718.
  4. Jones AL, Spring-Mills E. The liver and gallbladder. In: Histology Weiss L, ed., New York: Elsevier Biomedical; 1983. pp. 707–735.
  5. LaBrecque D. Liver regeneration: a picture emerges from the puzzle. Am J Gastroenterol 1994;89(8 Suppl):S86–S96.
  6. Burt AD, Day CP. Pathophysiology of the liver. In: Pathology of the Liver MacSween RNM, Burt AD, Portmann BC, et al., ed., New York: Churchill Livingstone; 2002. pp. 67–105.
  7. Watt AJ, Zhao R, Li J, et al. Development of the mammalian liver and ventral pancreas is dependent on GATA4. BMC Developmen Biol 2007;7(1):37–45. DOI: 10.1186/1471-213X-7-37.
  8. Moore KL, Dalley AF. Clinically oriented anatomy. 5th ed., Lippincott Williams and Wilkins; 2006. p. 1209.
  9. Matsumoto T, Kawakami M. The unit-concept of hepatic parenchyma—a re-examination based on angioarchitectural studies. Acta Pathol Jpn 1982;32(Suppl 2):285–314.
  10. Kogure K, Ishizaki M, Nemoto M, et al. A comparative study of the anatomy of rat and human livers. J Hepatobiliary Pancreat Surg 1999;6(2):171–175. DOI: 10.1007/s005340050101.
  11. MacSween RNM, Desmet VJ, Roskams T, et al. Developmental anatomy and normal structure. In: Pathology of the liver MacSween RNM, Burt AD, Portmann BC, et al., ed., New York: Churchill Livingstone; 2002. pp. 1–66.
  12. Jeejeebhoy K, Phillips MJ. Isolated mammalian hepatocytes in culture. Gastroenterology 1976;71(6):1086–1096. DOI: 10.1016/S0016-5085(76)80065-0.
  13. Sirica AE, Pitot AC. Drug metabolism and effects of carcinogens in cultural hepatic cells. Pharmacolog Re 1979;31(3):205–228.
  14. Braet F, Wisse E. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol 2002;1(1):1. DOI: 10.1186/1476-5926-1-1.
  15. Smedsrod B. Clearance function of scavenger endothelial cells. Comp Hepatol 2004;3(Suppl 1):S22. DOI: 10.1186/1476-5926-2-S1-S22.
  16. Breiner KM, Urban S, Schaller H. Endothelial cell-mediated uptake of a hepatitis B virus: a new concept of liver targeting of hepatotropic microorganisms. Hepatology 2001;34(4):803–808. DOI: 10.1053/jhep.2001.27810.
  17. Kmiec Z. Co-operation of liver cells in health and diseases. Adv Anatomy, Embryol Cell Biol 2001;161:3–12.
  18. Knook DL, Blansjaar N, Sleyster EC. Isolation and characterization of Kupffer and endothelial cells from the rat liver. Experimen Cell Res 1977;109(2):317–329. DOI: 10.1016/0014-4827(77)90011-8.
  19. Munthe-Kaas AC, Berg T, Seglen PO, et al. Distribution of lysosomal enzyme in different types of rat liver cells. Experimen Cell Res 1976;99(1):146–154. DOI: 10.1016/0014-4827(76)90689-3.
  20. Ratziu V, Friedman SL. Pathobiology of hepatic stellate cells. In: Functional heterogeneity of liver tissue: from cell lineage diversity to sublobular compartment-specific pathogenesis Vidal-Vanaclocha F, ed., Austin: R. G. Landes Company; 1997. pp. 133–160.
  21. Fehrenbach H, Weiskirchen R, Kasper M, et al. Upregulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology 2001;34(5):943–952. DOI: 10.1053/jhep.2001.28788.
  22. Albanis E, Safadi R, Friedman SL. Treatment of hepatic fibrosis: almost there. Curr Gastroenterol Rep 2003;5(1):48–56. DOI: 10.1007/s11894-003-0009-7.
  23. Mabuchi A, Mullaney I, Sheard P, et al. Role of hepatic stellate cells in the early phase of liver regeneration in rat: formation of tight adhesion to parenchymal cells. Comp Hepatol 2004;3(Suppl 1):S29. DOI: 10.1186/1476-5926-2-S1-S29.
  24. Katz N, Jungermann K, Seylers H. Autoregulatory shift from fructolysis to lactate gluconeogenesis in rat hepatocyte suspensions. The problem of metabolic zonation of liver parenchyma. Z Physiol Chem 1976;357(3):359–375. DOI: 10.1515/bchm2.1976.357.1.359.
  25. Fanti M, Singh S, Ledda-Columbano GM, et al. Tri-iodothyronine induces hepatocyte proliferation by protein kinase a-dependent β-catenin activation in rodents. Hepatology 2014;59(2014):2309–2320. DOI: 10.1002/hep.26775.
  26. Ippoliti R, Lendaro E, Benedetti PA, et al. Endocytosis of a chimera between human pro-urokinase and the plant toxin saporin: an unusual internalization mechanism. FASEB J 2000;14(10):1335–1344. DOI: 10.1096/fj.14.10.1335.
  27. Kalra A, Yetiskul E, Wehrle CJ, et al. Physiology, liver. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK535438/#article-24376.s1.
  28. Lindena J, Sommerfeld U, Hopfel C, et al. Catalytic enzyme activity concentration in tissues of man, dog, rabbit, guinea pig, rat and mouse. Approach to a quantitative diagnostic enzymology, III. Communication. J Clin Chem Clin Biochem 1986;24(1):35–47. DOI: 10.1515/cclm.1986.24.1.35.
  29. Sligbrand T. Present status and future trends of human alkaline phosphatases. Prog Clin Biol Res 1984;166:3–14.
  30. Thapa BR, Walia A. Liver function tests and their interpretation. Indian J Pediat 2007;74(7):663–671. DOI: 10.1007/s12098-007-0118-7.
  31. Scola RH, Werneck LC, Prevedello DM, et al. Diagnosis of dermatomyositis and polymyositis: a study of 102 cases. Arq Neuropsiquiatr 2000;58(3B):789–799. DOI: 10.1590/s0004-282x2000000500001.
  32. Lilford RJ, Bentham L, Girling A, et al. Birmingham and lambeth liver evaluation testing strategies (BALLETS): a prospective cohort study. Health Technol Assess 2013;17:1–307.
  33. Donnan P, McLernon D, Dillon J, et al. Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE). Health Technol Assess 2009;13(25):1–134. DOI: 10.3310/hta13250.
  34. Dufour DR, Lott JA, Nolte FS, et al. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000;46(12):2050–2068. DOI: 10.1093/clinchem/46.12.2050.
  35. Dufour DR, Lott JA, Nolte FS, et al. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem 2000;46(12):2027–2049. DOI: 10.1093/clinchem/46.12.2027.
  36. Williams R, Aspinall R, Bellis M, et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet 2014;384(9958):1953–1997. DOI: 10.1016/S0140-6736(14)61838-9.
  37. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterol 2002;123(4):1367–1384. DOI: 10.1053/gast.2002.36061.
  38. De Ritis F, Coltorti M, Giusti G. An enzymic test for the diagnosis of viral hepatitis: the transaminase serum activities. J Infect Dis 1957;101(3):219–223. DOI: 10.1093/infdis/101.3.219.
  39. Gómez-Moreno G, Guardia J, Cutando A. Interaction of paracetamol in chronic alcoholic patients. Importance for odontologists. See comment in PubMed Commons below Med Oral Patol Oral Cir Bucal 2008;13(4):E235–E238.
  40. Botros M, Sikaris KA. The de ritis ratio: the test of time. Clin Biochem Rev 2013;34(3):117–130.
  41. Botros M, Sikaris KA, Lu ZX, et al. The short term prognostic usefulness of the De Ritis ratio. Clin Biochem Rev 2013;34:S18.
  42. Erden A, Esmeray K, Karagöz H, et al. Acute liver failure caused by mushroom poisoning: a case report and review of the literature. Int Med Case Rep J 2013;6:85–90. DOI: 10.2147/IMCRJ.S53773.
  43. Nalpas B, Vassault A, Le Guillou A, et al. Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatol 1984;4(5):893–896. DOI: 10.1002/hep.1840040517.
  44. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34(3):274–285. DOI: 10.1111/j.1365-2036.2011.04724.x.
  45. Giovanni G, Gambino R, Cassader M, et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43(8):617–649. DOI: 10.3109/07853890.2010.518623.
  46. Kulkarni A, Garg M, Agrawal RM, et al. Analysis and interpretation of classic liver enzymes. Pract Gastroent 2018;XLII(11):76–86. https://practicalgastro.com/wp-content/uploads/2019/07/Analysis-and-Interpretation-of-Classic-Liver-Enzymes.pdf.
  47. Siest G, Schiele F, Galteau MM, et al. Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem 1975;21(8):1077–1087. DOI: 10.1093/clinchem/21.8.1077.
  48. Yasuda K, Okuda K, Endo N, et al. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterol 1995;109(4):1295–1300. DOI: 10.1016/0016-5085(95)90591-x.
  49. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterol 1990;99(5):1408–1413. DOI: 10.1016/0016-5085(90)91169-7.
  50. Vajro P, Lofrano MM, Fontanella A, et al. Immunoglobulin complexed AST (“macro-AST”) in an asymptomatic child with persistent hyper-transaminasemia. J Pediatr Gastroenterol Nutr 1992;15(4):458–460. DOI: 10.1097/00005176-199211000-00018.
  51. Stapleton JT. Host immune response to hepatitis A virus. J Infect Dis 1995;175(Suppl 1):S9–S14. DOI: 10.1093/infdis/171.supplement_1.s9.
  52. Levinson M, Holbert J, Blackwell C, et al. Serum gammaglutamyl transpeptidase: its specificity and clinical value. South Med J 1979;72(7):837–841. DOI: 10.1097/00007611-197907000-00021.
  53. Pratt DS. Evaluation of liver function. In: Kasper D, Fauci A, Hauser S, et al., ed. Harrison's principles of internal medicine. 19th ed., New York, NY: McGraw-Hill; 2015. pp. 1995–1998.
  54. Anderson GF, Barnhart MI. Intracellular localization of prothrombin. Proc Soc Exp Biol Med 1964;116(1):1–4. DOI: 10.3181/00379727-116-29142.
  55. Jefferson DM, Reid LM, Giambrone MA, et al. Effects of dexamethasone on albumin and collagen gene expression in primary cultures of adult rat hepatocytes. Hepatology 1985;5(1):14–19. DOI: 10.1002/hep.1840050105.
  56. Rothschild MA, Oratz M, Zimmon D, et al. Albumin synthesis in cirrhotic subjects studied with carbonate 14 C. J Clin Invest 1969;48(2):344–349. DOI: 10.1172/JCI105990.
  57. Hasch E, Jarnum S, Tygstrup N. Albumin synthesis rate as a measure of liver function in patients with cirrhosis. Arch Intern Med 1967;182(1):38–44. DOI: 10.1111/j.0954-6820.1967.tb11502.x.
  58. Kasarala G, Tillmann HL. Standard liver tests. Clin Liver Dis 2016;8(1):13–18. DOI: 10.1002/cld.562.
  59. Friedman SF, Martin P, Munoz JS. Laboratory evaluation of the patient with liver disease. Hepatology, a textbook of liver disease. Philedelphia: Saunders Publication; 2003. vol. 1 pp. 661–709.
  60. Daniel SP, Marshall MK. Evaluation of the liver: laboratory tests. Schiff's diseases of the liver. 8th ed., USA: JB Lippincott Publications; 1999. pp. 205–239.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.